Altogether, these findings demonstrated that the chaperoning of SRC kinase by HSP90 contributed to the proliferation and growth of T-ALL and B-ALL cells, which provides novel targeting strategies for ALL treatment. The gene discussed is HSP90AB1; the disease is acute lymphoblastic leukemia.